Department of Surgery in Norrköping and Department of Biomedical and Clinical Sciences, Linköping University, Norrköping, Sweden.
Department of Surgery in Norrköping and Department of Biomedical and Clinical Sciences, Linköping University, Norrköping, Sweden.
HPB (Oxford). 2024 Sep;26(9):1131-1140. doi: 10.1016/j.hpb.2024.05.008. Epub 2024 May 22.
The aim of this retrospective observational study was to investigate the geographical or sex differences in patients with synchronous colorectal liver metastases (sCRLM) in terms of assessment by a multidisciplinary team conference (MDT), curative treatment, and overall survival.
All sCRLM patients in the South-East Health Care Region of Sweden from 2009 to 2015 were included (n = 615). Data were derived from the Swedish Colorectal Cancer Registry, Swedish Registry of Liver and Bile Surgery and medical records.
Patients who had a hepatobiliary unit (HBU) at the nearest hospital were more likely to undergo liver surgery (HBU+, 37% (n = 106), compared to HBU-, 22% (n = 60); p = 0.001) and had a better median survival (p < 0.001). No sex differences were observed. In multivariate Cox regression analyses of overall survival, assessment by an MDT that included a liver surgeon was independently linked to better survival (HR 0.574, 0.433-0.760).
There were no sex differences in access to liver surgery or overall survival, however, there were geographical inequalities, where residency near a hospital with HBU was associated with increased overall survival and the possibility to receive liver surgery. Assessment at MDT with liver surgeon present was associated with greater survival, indicating its important role for treatment.
本回顾性观察研究旨在探讨多学科团队评估、根治性治疗和总生存方面同步结直肠癌肝转移(sCRLM)患者的地理或性别差异。
纳入 2009 年至 2015 年瑞典东南部卫生保健区所有 sCRLM 患者(n=615)。数据来源于瑞典结直肠癌登记处、瑞典肝和胆管外科登记处和病历。
距最近医院有肝胆单位(HBU)的患者更有可能接受肝切除术(HBU+,37%(n=106),HBU-,22%(n=60);p=0.001),中位生存期更长(p<0.001)。未观察到性别差异。多变量 Cox 回归分析总生存,包括肝外科医生的 MDT 评估与更好的生存独立相关(HR 0.574,0.433-0.760)。
在获得肝切除术或总体生存方面,无性别差异,但存在地理不平等,居住在有 HBU 的医院附近与总体生存和接受肝切除术的可能性增加相关。有肝外科医生参与的 MDT 评估与更高的生存率相关,表明其对治疗具有重要作用。